Cold atmospheric plasma devices for medical issues.

Department of Dermatology, Allergology and Environmental Medicine, Hospital Munich Schwabing, Koelner Platz 1, Munich 80804, Germany.
Expert Review of Medical Devices (Impact Factor: 2.43). 05/2013; 10(3):367-77. DOI: 10.1586/erd.13.4
Source: PubMed

ABSTRACT Cold atmospheric plasma science is an innovative upcoming technology for the medical sector. The plasma composition and subsequent effects on cells, tissues and pathogens can vary enormously depending on the plasma source, the plasma settings and the ambient conditions. Cold atmospheric plasmas consist of a highly reactive mix of ions and electrons, reactive molecules, excited species, electric fields and to some extent also UV radiation. In the last year, this partly ionized gas has been demonstrated to have a broad antimicrobial activity, while resistance and resistance development are unlikely. Furthermore, recent research has indicated that plasmas also have a strong influence on various cell lines and cell functions, including anticancer properties. This review summarizes the major plasma designs available and their main benefits, as well as assessing possible risks of this new technology.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Recurrent hemorrhage in patients with severe radiation proctitis is very common. It is often refractory to medical therapy. Endoscopic and surgical treatment may be required when conservative medical therapy fails. The aim of this study was to assess the therapeutic results of the Argon Plasma Coagulator (APC) (ERBE USA, Inc., Marietta, GA, USA) application in patients with radiation proctitis-induced hemorrhage. Forty patients with radiation-induced proctitis causing severe bleeding, who had failed conservative medical management were treated endoscopically. Twenty-one patients in this group required blood transfusions. APC application was used in 40 patients with only one failure. The failed patient underwent formalin application using 4% formalin solution with resolution of the bleeding. Argon plasma coagulation application is a safe, well-tolerated treatment option and, historically, has been superior to Nd:YAG laser ablation.
    Surgical Endoscopy 05/2002; 16(4):707-10. · 3.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A new modality, the Portrait plasma skin regeneration (PSR(3)) system, allows precise and rapid treatment of photo-damaged skin, with controlled thermal injury and modification. Radio frequency (RF) energy converts nitrogen gas into plasma within the handpiece. Rapid heating of the skin occurs as the plasma rapidly gives up energy to the skin. This energy transfer is not chromophore dependent. The gold standard, carbon dioxide (CO(2)) laser resurfacing, has decreased in popularity due to high morbidity and downtime. There is demand for a technology that can provide the degree of improvement obtained with resurfacing without the complications associated with its use. This study evaluated the PSR(3) technology in full facial procedures. A two-site prospective study evaluated safety and efficacy for a single pass treatment of the full face using the Portrait PSR(3) system. Improvement in skin texture, tone, fine lines, dyschromia, and rhytides were assessed. Two-millimeter punch biopsy specimens were taken pre- and 90 days post-treatment. Follow-up was performed at days 2, 5, 7, 30, and 90 post-treatment to monitor recovery, improvement, and any subsequent sequelae. Patients developed erythema and edema shortly after treatment, with no immediate epidermal loss or charring. Epidermal loss occurred in the subsequent 24-48 h followed by epidermal recovery in approximately 7 days. Histological investigation showed regenerative epidermal and dermal architecture. The Rhytec Portrait PSR(3) system provides an attractive alternative to standard lasers that is well tolerated by patients, stimulates collagen remodeling, and provides excellent clinical outcomes.
    Lasers in Medical Science 07/2007; 22(2):101-9. · 2.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasma medicine is emerging worldwide, and some promising applications seem to be near the horizon. Direct therapeutic plasma application as the central field of plasma medicine will bring physical plasmas directly on or in a human (or animal) body. Campus PlasmaMed is a research association supported by the German Federal Ministry of Education and Research (BMBF), concentrated in the northeast of Germany and founded to explore promising and safe applications of atmospheric-pressure plasmas in medical therapy based on systematic and interdisciplinary basic research on the interactions of plasma components with living systems. Whereas a broad spectrum of plasma sources dedicated for biomedical applications has been reported during recent years, mainly two basic principles of plasma sources are used in the Campus PlasmaMed: atmospheric-pressure plasma jets and dielectric barrier discharges. A comprehensive assessment of potential risk factors, such as gas temperature, power transfer from plasma to the target, (V)UV radiation emission, or the generation of toxic gases and its release into the adjacencies, which could be dangerous for patients and therapists, has to be done as a basic precondition before any biomedical experiments can be started or a potential therapeutic application can be taken into consideration. Despite the fact that the initial plasma-source characterization and optimization are in the main responsibility of plasma physicists and engineers, potential users from the biomedical field should be integrated as soon as possible to include special needs and constraints for specific applications during early steps of development. This multidisciplinary research cooperation among plasma scientists and engineers on the one side and life scientists and clinicians on the other is one of the main characteristics of the Campus PlasmaMed. Such interdisciplinary cooperation is more than ever required for the characterization of biological effects of plasma sources- - , which has to be realized by a multistep program, starting with the investigations of plasma–liquid interactions and including a broad spectrum of in vitro tests with cells, as well as cell and tissue cultures up to isolated tissues or organs to be proved finally with animal experiments and clinical trials. Because there are no standardized criteria so far according to which atmospheric-pressure plasma sources can be assessed as to their suitability for medical applications, interdisciplinary results from plasma medical research have to be transferred into rules and standards to guarantee successful and safe practical application, including economic exploitation of plasma-medical research results.
    IEEE Transactions on Plasma Science 05/2011; · 0.87 Impact Factor


Available from
May 21, 2014